Do active site conformations of small ligands correspond to low free-energy solution structures?
暂无分享,去创建一个
[1] G. Klebe. The use of composite crystal-field environments in molecular recognition and the de novo design of protein ligands. , 1994, Journal of molecular biology.
[2] Richard A. Friesner,et al. Solvation Free Energies of Peptides: Comparison of Approximate Continuum Solvation Models with Accurate Solution of the Poisson−Boltzmann Equation , 1997 .
[3] D W Zaharevitz,et al. The discovery of novel, structurally diverse protein kinase C agonists through computer 3D-database pharmacophore search. Molecular modeling studies. , 1994, Journal of medicinal chemistry.
[4] H M Holden,et al. The binding of L-valyl-L-tryptophan to crystalline thermolysin illustrates the mode of interaction of a product of peptide hydrolysis. , 1989, The Journal of biological chemistry.
[5] Dorica Mayer,et al. A unique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studies , 1987, J. Comput. Aided Mol. Des..
[6] A. Leslie. Refined crystal structure of type III chloramphenicol acetyltransferase at 1.75 A resolution. , 1990, Journal of molecular biology.
[7] M. Noble,et al. The adaptability of the active site of trypanosomal triosephosphate isomerase as observed in the crystal structures of three different complexes , 1991, Proteins.
[8] D E Tronrud,et al. Crystallographic structural analysis of phosphoramidates as inhibitors and transition-state analogs of thermolysin. , 1989, European journal of biochemistry.
[9] J. Warwicker,et al. Calculation of the electric potential in the active site cleft due to alpha-helix dipoles. , 1982, Journal of molecular biology.
[10] W L Jorgensen,et al. Rusting of the lock and key model for protein-ligand binding. , 1991, Science.
[11] M. Karplus,et al. Functionality maps of binding sites: A multiple copy simultaneous search method , 1991, Proteins.
[12] T Honma,et al. Novel angiotensin II receptor antagonists. Design, synthesis, and in vitro evaluation of dibenzo[a,d]cycloheptene and dibenzo[b,f]oxepin derivatives. Searching for bioisosteres of biphenylyltetrazole using a three-dimensional search technique. , 1995, Journal of medicinal chemistry.
[13] Robert Huber,et al. On the disordered activation domain in trypsinogen: chemical labelling and low‐temperature crystallography , 1982 .
[14] Garland R. Marshall,et al. Sampling conformational hyperspace: Techniques for improving completeness , 1995, J. Comput. Aided Mol. Des..
[15] J. Skehel,et al. Refinement of the influenza virus hemagglutinin by simulated annealing. , 1991, Journal of molecular biology.
[16] David E. Clark,et al. Active-site-directed 3D database searching: Pharmacophore extraction and validation of hits , 1996, J. Comput. Aided Mol. Des..
[17] R. Sheridan,et al. The ensemble approach to distance geometry: application to the nicotinic pharmacophore. , 1986, Journal of medicinal chemistry.
[18] Anil K. Jain,et al. Algorithms for Clustering Data , 1988 .
[19] Y. Martin,et al. 3D database searching in drug design. , 1992, Journal of medicinal chemistry.
[20] Garland R. Marshall,et al. Constrained search of conformational hyperspace , 1989, J. Comput. Aided Mol. Des..
[21] Peter G. Schultz,et al. The Immunological Evolution of Catalysis , 1996, Science.
[22] G J Williams,et al. The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1977, Journal of molecular biology.
[23] Gerhard Klebe,et al. What Can We Learn from Molecular Recognition in Protein–Ligand Complexes for the Design of New Drugs? , 1996 .
[24] J. Wendoloski,et al. Structural origins of high-affinity biotin binding to streptavidin. , 1989, Science.
[25] M C Nicklaus,et al. Conformational changes of small molecules binding to proteins. , 1995, Bioorganic & medicinal chemistry.